Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections

Chimpanzee Adenovirus Vector Ebola Vaccine

(2017) Julie E. Ledgerwood et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates

(2015) Angiolo Pierantoni et al.   Molecular Therapy-Methods & Clinical Development

Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves

(2014) G. Taylor et al.   JOURNAL OF GENERAL VIROLOGY

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals

(2014) Susanne H. Hodgson et al.   JOURNAL OF INFECTIOUS DISEASES

Development of an Adenovirus-Based Respiratory Syncytial Virus Vaccine: Preclinical Evaluation of Efficacy, Immunogenicity, and Enhanced Disease in a Cotton Rat Model

(2014) E. Kim et al.   JOURNAL OF VIROLOGY

A Phase Ia Study to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 CS Administered Alone and with MVA CS

(2014) Eoghan de Barra et al.   PLoS One

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory

(2014) L. Swadling et al.   Science Translational Medicine

Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials

(2013) Stefania Capone et al.   Expert Review of Vaccines

Genetic Vaccine for Respiratory Syncytial Virus Provides Protection Without Disease Potentiation

(2013) Teresa R Johnson et al.   MOLECULAR THERAPY

Cellular immune correlates of protection against symptomatic pandemic influenza

(2013) Saranya Sridhar et al.   NATURE MEDICINE

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

(2013) J. S. McLellan et al.   SCIENCE

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

(2013) Katie J. Ewer et al.   Nature Communications

Adults 65 Years Old and Older Have Reduced Numbers of Functional Memory T Cells to Respiratory Syncytial Virus Fusion Protein

(2012) Anu Cherukuri et al.   Clinical and Vaccine Immunology

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

(2012) Tom M Wilkinson et al.   NATURE MEDICINE

Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man

(2012) E. Barnes et al.   Science Translational Medicine

Respiratory syncytial virus vaccine development

(2011) Julia L Hurwitz   Expert Review of Vaccines

Bovine respiratory syncytial virus ISCOMs—Immunity, protection and safety in young conventional calves

(2011) Sara Hägglund et al.   VACCINE

Age-dependent differences in the pathogenesis of bovine respiratory syncytial virus infections related to the development of natural immunocompetence

(2010) A. F. G. Antonis et al.   JOURNAL OF GENERAL VIROLOGY

A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate

(2010) M. Chen et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus

(2009) R. Kohlmann et al.   JOURNAL OF VIROLOGY

A quantitative assessment of primary and secondary immune responses in cattle using a B cell ELISPOT assay

(2008) Eric A. Lefevre et al.   VETERINARY RESEARCH